User menu

Accès à distance ? S'identifier sur le proxy UCLouvain

Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited

Primary tabs

download
  • Open access
  • PDF
  • 467.31 K
Sandercock, Peter Lindley, Richard Wardlaw, Joanna Dennis, Martin Innes, Karen Peeters, André [UCL] Lundstrom, Erik

Background: Intravenous recombinant tissue plasminogen activator (rtPA) is approved in Europe for use in patients with acute ischaemic stroke who meet strictly defined criteria. IST-3 sought to improve the external validity and precision of the estimates of the overall treatment effects (efficacy and safety) of rtPA in acute ischaemic stroke, and to determine whether a wider range of patients might benefit.Design: International, multi-centre, prospective, randomized, open, blinded endpoint (PROBE) trial of intravenous rtPA in acute ischaemic stroke. Suitable patients had to be assessed and able to start treatment within 6 hours of developing symptoms, and brain imaging must have excluded intracranial haemorrhage and stroke mimics.Results: The initial pilot phase was double blind and then, on 01/08/2003, changed to an open design. Recruitment began on 05/05/2000 and closed on 31/07/2011, by which time 3035 patients had been included, only 61 (2%) of whom met the criteria for the 2003 European approval for thrombolysis. 1617 patients were aged over 80 years at trial entry. The analysis plan will be finalised, without reference to the unblinded data, and published before the trial data are unblinded in early 2012. The main trial results will be presented at the European Stroke Conference in Lisbon in May 2012 with the aim to publish simultaneously in a peer-reviewed journal. The trial result will be presented in the context of an updated Cochrane systematic review. We also intend to include the trial data in an individual patient data meta-analysis of all the relevant randomised trials.Conclusion: The data from the trial will: improve the external validity and precision of the estimates of the overall treatment effects (efficacy and safety) of iv rtPA in acute ischaemic stroke; provide: new evidence on the balance of risk and benefit of intravenous rtPA among types of patients who do not clearly meet the terms of the current EU approval; and, provide the first large-scale randomised evidence on effects in patients over 80, an age group which had largely been excluded from previous acute stroke trials.Trial registration: ISRCTN25765518. © 2011 Sandercock et al; licensee BioMed Central Ltd.

Document type Article de périodique (Journal article) – Article de recherche
Access type Accès libre
Publication date 2011
Language Anglais
Journal information "Trials" - Vol. 12, p. 252 [1-9] (2011)
Peer reviewed yes
Publisher BioMed Central ((United Kingdom) London)
e-issn 1745-6215
Publication status Publié
Affiliations UCL - SSS/IONS/NEUR - Clinical Neuroscience
UCL - (SLuc) Service de neurologie
Links
  1. Sandercock Peter, , Lindley Richard, Wardlaw Joanna, Dennis Martin, Lewis Steff, Venables Graham, Kobayashi Adam, Czlonkowska Anna, Berge Eivind, Slot Karsten Bruins, Murray Veronica, Peeters Andre, Hankey Graeme, Matz Karl, Brainin Michael, Ricci Stefano, Celani Maria Grazia, Righetti Enrico, Cantisani Teresa, Gubitz Gord, Phillips Steve, Arauz Antonio, Prasad Kameshwar, Correia Manuel, Lyrer Phillippe, The third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke, 10.1186/1745-6215-9-37
  2. Warlow Charles, MRC European Carotid Surgery Trial: interim results for symptomatic patients with severe (70-99%) or with mild (0-29%) carotid stenosis, 10.1016/0140-6736(91)92916-p
  3. Peto R., Baigent C., Trials: the next 50 years, 10.1136/bmj.317.7167.1170
  4. Collins Rory, MacMahon Stephen, Reliable assessment of the effects of treatment on mortality and major morbidity, I: clinical trials, 10.1016/s0140-6736(00)03651-5
  5. Ware James H., Hamel Mary Beth, Pragmatic Trials — Guides to Better Patient Care?, 10.1056/nejmp1103502
  6. McMahon Alex D., Study control, violators, inclusion criteria and defining explanatory and pragmatic trials, 10.1002/sim.1120
  7. Hacke Werner, Kaste Markku, Bluhmki Erich, Brozman Miroslav, Dávalos Antoni, Guidetti Donata, Larrue Vincent, Lees Kennedy R., Medeghri Zakaria, Machnig Thomas, Schneider Dietmar, von Kummer Rüdiger, Wahlgren Nils, Toni Danilo, Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke, 10.1056/nejmoa0804656
  8. Kent David M, Rothwell Peter M, Ioannidis John PA, Altman Doug G, Hayward Rodney A, Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal, 10.1186/1745-6215-11-85
  9. , Can We Improve the Statistical Analysis of Stroke Trials?: Statistical Reanalysis of Functional Outcomes in Stroke Trials * OAST Supplemental Appendix I: Statistical Tests Compared (see Table I) * OAST Supplemental Appendix II: Supplementary Analyses * OAST Supplemental Appendix III: Trial Data (see Tables II and III) * OAST Supplemental Appendix IV: Results (see Table IV), 10.1161/strokeaha.106.474080
  10. Saver J. L., Novel End Point Analytic Techniques and Interpreting Shifts Across the Entire Range of Outcome Scales in Acute Stroke Trials, 10.1161/strokeaha.107.488536
  11. Hacke Werner, Kaste Markku, Fieschi Cesare, von Kummer Rüdiger, Davalos Antoni, Meier Dieter, Larrue Vincent, Bluhmki Erich, Davis Stephen, Donnan Geoffrey, Schneider Dietmar, Diez-Tejedor Exuperio, Trouillas Paul, Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II), 10.1016/s0140-6736(98)08020-9
  12. Sanossian Nerses, Ovbiagele Bruce, Prevention and management of stroke in very elderly patients, 10.1016/s1474-4422(09)70259-5
  13. Wardlaw JM, Murray V, Berge E, del Zoppo GJ: Thrombolysis for acute ischaemic stroke. Cochrane Database Syst Rev. 2009, CD000213-4
  14. Konig I. R., Ziegler A., Bluhmki E., Hacke W., Bath P. M.W., Sacco R. L., Diener H. C., Weimar C., , Predicting Long-Term Outcome After Acute Ischemic Stroke: A Simple Index Works in Patients From Controlled Clinical Trials, 10.1161/strokeaha.107.505867
Bibliographic reference Sandercock, Peter ; Lindley, Richard ; Wardlaw, Joanna ; Dennis, Martin ; Innes, Karen ; et. al. Update on the third international stroke trial (IST-3) of thrombolysis for acute ischaemic stroke and baseline features of the 3035 patients recruited. In: Trials, Vol. 12, p. 252 [1-9] (2011)
Permanent URL http://hdl.handle.net/2078.1/163977